A citation-based method for searching scientific literature

Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
Times Cited: 59







List of co-cited articles
429 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
155
33

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
39
41

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
69
18

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
155
18

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
50
20

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
I Esteban, M Vilaró, E Adrover, A Angulo, E Carrasco, N Gadea, A Sánchez, T Ocaña, G Llort, R Jover,[...]. Psychooncology 2018
16
62

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
283
15


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
15

Psychological distress related to BRCA testing in ovarian cancer patients.
Merete Bjørnslett, Alv A Dahl, Øystein Sørebø, Anne Dørum. Fam Cancer 2015
16
56

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
13

A taxonomy of medical uncertainties in clinical genome sequencing.
Paul K J Han, Kendall L Umstead, Barbara A Bernhardt, Robert C Green, Steven Joffe, Barbara Koenig, Ian Krantz, Leo B Waterston, Leslie G Biesecker, Barbara B Biesecker. Genet Med 2017
50
16

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
143
11

Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
Anita Y Kinney, Laurie E Steffen, Barbara H Brumbach, Wendy Kohlmann, Ruofei Du, Ji-Hyun Lee, Amanda Gammon, Karin Butler, Saundra S Buys, Antoinette M Stroup,[...]. J Clin Oncol 2016
57
12

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
216
11

How do research participants perceive "uncertainty" in genome sequencing?
Barbara B Biesecker, William Klein, Katie L Lewis, Tyler C Fisher, Martha Frances Wright, Leslie G Biesecker, Paul K Han. Genet Med 2014
49
14

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
294
11

Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
Chanita Hughes Halbert, Jill E Stopfer, Jasmine McDonald, Benita Weathers, Aliya Collier, Andrea B Troxel, Susan Domchek. J Clin Oncol 2011
49
14

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
25
28

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.
Johanna Ringwald, Christina Wochnowski, Kristin Bosse, Katrin Elisabeth Giel, Norbert Schäffeler, Stephan Zipfel, Martin Teufel. J Genet Couns 2016
38
15

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.
Kristi D Graves, Patti Vegella, Elizabeth A Poggi, Beth N Peshkin, Angie Tong, Claudine Isaacs, Clinton Finch, Scott Kelly, Kathryn L Taylor, George Luta,[...]. Cancer Epidemiol Biomarkers Prev 2012
52
11

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
472
10

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
193
10

Multigene Panel Testing in Oncology Practice: How Should We Respond?
Allison W Kurian, James M Ford. JAMA Oncol 2015
42
14

Known unknowns: building an ethics of uncertainty into genomic medicine.
Ainsley J Newson, Samantha J Leonard, Alison Hall, Clara L Gaff. BMC Med Genomics 2016
39
15

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Michael J Hall, Susan M Domchek, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer,[...]. J Natl Cancer Inst 2018
16
37

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
120
8

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
761
8

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
Tammy M Beran, Annette L Stanton, Lorna Kwan, Joyce Seldon, Julienne E Bower, Andrea Vodermaier, Patricia A Ganz. Ann Behav Med 2008
51
9

Psychiatric implications of cancer genetic testing.
April Malia Hirschberg, Gayun Chan-Smutko, William F Pirl. Cancer 2015
24
20

Experiences with obtaining informed consent for genomic sequencing.
Barbara A Bernhardt, Myra I Roche, Denise L Perry, Sarah R Scollon, Ashley N Tomlinson, Debra Skinner. Am J Med Genet A 2015
60
8

Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
W Eijzenga, E M A Bleiker, D E E Hahn, I Kluijt, G N Sidharta, C Gundy, N K Aaronson. Psychooncology 2014
22
22

Cancer genetic counseling: communication and counselees' post-visit satisfaction, cognitions, anxiety, and needs fulfillment.
Arwen H Pieterse, Alexandra M van Dulmen, Frits A Beemer, Jozien M Bensing, Margreet G E M Ausems. J Genet Couns 2007
46
10

Gene panel testing for inherited cancer risk.
Michael J Hall, Andrea D Forman, Robert Pilarski, Georgia Wiesner, Veda N Giri. J Natl Compr Canc Netw 2014
77
8

Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.
Kelly Hitch, Galen Joseph, Jenna Guiltinan, Jessica Kianmahd, Janey Youngblom, Amie Blanco. J Genet Couns 2014
41
12

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, Michael F Walsh, Vijai Joseph, Zsofia K Stadler, Katherine L Nathanson, Judy E Garber, Fergus J Couch, Kenneth Offit,[...]. J Clin Oncol 2016
95
8


The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
79
8

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
59
8

Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
8

Benefit finding in response to BRCA1/2 testing.
Carissa A Low, Julienne E Bower, Lorna Kwan, Joyce Seldon. Ann Behav Med 2008
27
18

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
62
8

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
64
8

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
150
6

Cancer Genetic Counseling and Testing in an Era of Rapid Change.
Gillian W Hooker, Keelia Rhoads Clemens, John Quillin, Kristen J Vogel Postula, Pia Summerour, Rebecca Nagy, Adam H Buchanan. J Genet Couns 2017
23
17

Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.
Kathleen R Blazer, Bita Nehoray, Ilana Solomon, Mariana Niell-Swiller, Julie O Culver, Gwen C Uman, Jeffrey N Weitzel. Genet Test Mol Biomarkers 2015
32
12

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Thomas Paul Slavin, Mariana Niell-Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R Blazer, Jeffrey N Weitzel. Front Oncol 2015
64
6

Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.
Lotte Krabbenborg, L E L M Vissers, J Schieving, T Kleefstra, E J Kamsteeg, J A Veltman, M A Willemsen, S Van der Burg. J Genet Couns 2016
39
10

Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.
Allyn McConkie Rosell, Loren D M Pena, Kelly Schoch, Rebecca Spillmann, Jennifer Sullivan, Stephen R Hooper, Yong-Hui Jiang, Nicolas Mathey-Andrews, David B Goldstein, Vandana Shashi. J Genet Couns 2016
42
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.